Omnipulse Biosciences, Inc. — Form D

Omnipulse Biosciences, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-02. The offering totals $12.5M, of which $7.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-01-02
• Form: D
• Accession: 0001976713-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $12.5M
• Amount sold: $7.0M
• Remaining: $5.5M
• Investors: 2
• Date of first sale: 2023-12-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-501260

Issuer

• Name: Omnipulse Biosciences, Inc.
• CIK: 0001976713
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 238 Main Street, Cambridge, MA, 02142
• Phone: 978-999-2040

Officers, directors & promoters (9)

More

• CIK 1976713 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search